Dr. Andrew J Weickhardt
Claim this profileAustin Health
Area of expertise
Solid Tumors
Andrew J Weickhardt has run 4 trials for Solid Tumors. Some of their research focus areas include:
Lung Cancer
Andrew J Weickhardt has run 3 trials for Lung Cancer. Some of their research focus areas include:
Clinical Trials Andrew J Weickhardt is currently running
AU-007
for Advanced Cancer
This is a first in human, open-label, multi-center Phase 1 / 2 study to evaluate the safety, tolerability, and initial efficacy of AU-007 in patients with advanced solid tumors. AU-007 will be administered either as a monotherapy, or in combination with a single loading dose of aldesleukin, or with both AU-007 and aldesleukin given every 2 weeks (Q2w). Once the recommended phase 2 dose (RP2D) of AU-007 plus aldesleukin was determined, (AU-007 Q2w plus a single loading dose of aldesleukin), AU-007 plus aldesleukin is also being administered with avelumab or nivolumab.
Recruiting
1 award
Phase 1 & 2
8 criteria
BEP Chemotherapy
for Germ Cell Cancer
The purpose of this study is to determine whether accelerated BEP chemotherapy is more effective than standard BEP chemotherapy in males with intermediate and poor-risk metastatic germ cell tumours.
Recruiting
2 awards
Phase 3
6 criteria
More about Andrew J Weickhardt
Clinical Trial Related
4 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Andrew J Weickhardt has experience with
- NL-201
- Pembrolizumab
- MGC018
- MGA012
- Etoposide
- Cisplatin
Breakdown of trials Andrew J Weickhardt has run
Solid Tumors
Lung Cancer
Squamous Cell Carcinoma
Bladder Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Andrew J Weickhardt specialize in?
Andrew J Weickhardt focuses on Solid Tumors and Lung Cancer. In particular, much of their work with Solid Tumors has involved Stage IV patients, or patients who are FGFR positive.
Is Andrew J Weickhardt currently recruiting for clinical trials?
Yes, Andrew J Weickhardt is currently recruiting for 2 clinical trials in Heidelberg Victoria. If you're interested in participating, you should apply.
Are there any treatments that Andrew J Weickhardt has studied deeply?
Yes, Andrew J Weickhardt has studied treatments such as NL-201, Pembrolizumab, MGC018.
What is the best way to schedule an appointment with Andrew J Weickhardt?
Apply for one of the trials that Andrew J Weickhardt is conducting.
What is the office address of Andrew J Weickhardt?
The office of Andrew J Weickhardt is located at: Austin Health, Heidelberg, Victoria 3084 Australia. This is the address for their practice at the Austin Health.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.